Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | ClHO4 |
| Molecular Weight | 100.459 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
OCl(=O)(=O)=O
InChI
InChIKey=VLTRZXGMWDSKGL-UHFFFAOYSA-N
InChI=1S/ClHO4/c2-1(3,4)5/h(H,2,3,4,5)
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Perchloric acid in the cytochemistry of pentose nucleic acid. | 1949 Nov 4 |
|
| Loss of ATP in micromolar amounts after perchloric acid treatment. | 1976 Nov 5 |
|
| Purification and characterization of (per)chlorate reductase from the chlorate-respiring strain GR-1. | 1999 Nov |
|
| Cell necrosis and apoptosis are differentially regulated during goitre development and iodine-induced involution. | 2002 Feb |
|
| Functional activity of human sodium/iodide symporter in tumor cell lines. | 2003 Feb |
|
| Probasin promoter (ARR(2)PB)-driven, prostate-specific expression of the human sodium iodide symporter (h-NIS) for targeted radioiodine therapy of prostate cancer. | 2003 Nov 15 |
|
| Human 3'-phosphoadenosine 5'-phosphosulfate synthetase (isoform 1, brain): kinetic properties of the adenosine triphosphate sulfurylase and adenosine 5'-phosphosulfate kinase domains. | 2004 Apr 13 |
|
| Establishment of a human hepatocellular carcinoma cell line highly expressing sodium iodide symporter for radionuclide gene therapy. | 2004 Sep |
|
| A novel therapeutic strategy for medullary thyroid cancer based on radioiodine therapy following tissue-specific sodium iodide symporter gene expression. | 2005 Aug |
|
| Carbonic anhydrase inhibitors. Inhibition of isozymes I, II, IV, V, and IX with anions isosteric and isoelectronic with sulfate, nitrate, and carbonate. | 2005 Feb 1 |
|
| The BeWo choriocarcinoma cell line as a model of iodide transport by placenta. | 2005 May |
|
| Development of a rat dosimetry model for bromate. | 2006 Apr 17 |
|
| Evaluation of gene expression endpoints in the context of a Xenopus laevis metamorphosis-based bioassay to detect thyroid hormone disruptors. | 2006 Jan 5 |
|
| Effects of prolonged exposure to perchlorate on thyroid and reproductive function in zebrafish. | 2007 Apr |
|
| Cell-based imaging of sodium iodide symporter activity with the yellow fluorescent protein variant YFP-H148Q/I152L. | 2007 Feb |
|
| Duox expression and related H2O2 measurement in mouse thyroid: onset in embryonic development and regulation by TSH in adult. | 2007 Mar |
|
| Identification of gene expression indicators for thyroid axis disruption in a Xenopus laevis metamorphosis screening assay. Part 1. Effects on the brain. | 2007 May 31 |
|
| Identification of gene expression indicators for thyroid axis disruption in a Xenopus laevis metamorphosis screening assay. Part 2. Effects on the tail and hindlimb. | 2007 May 31 |
|
| Perchlorate and ethylenethiourea induce different histological and molecular alterations in a non-mammalian vertebrate model of thyroid goitrogenesis. | 2009 Jan 27 |
|
| Thyroid hormone may regulate mRNA abundance in liver by acting on microRNAs. | 2010 Aug 13 |
|
| Perchlorate transport and inhibition of the sodium iodide symporter measured with the yellow fluorescent protein variant YFP-H148Q/I152L. | 2010 Mar 15 |
|
| Inhibition of thyroid hormone release from cultured amphibian thyroid glands by methimazole, 6-propylthiouracil, and perchlorate. | 2010 Nov |
|
| Goitrogenic anions, thyroid-stimulating hormone, and thyroid hormone in infants. | 2010 Sep |
|
| The effects of perchlorate on thyroidal gene expression are different from the effects of iodide deficiency. | 2011 |
|
| The effects of ammonium perchlorate on thyroid homeostasis and thyroid-specific gene expression in rat. | 2012 Aug |
Patents
| Name | Type | Language | ||
|---|---|---|---|---|
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
m8537
Created by
admin on Fri Dec 15 18:48:42 GMT 2023 , Edited by admin on Fri Dec 15 18:48:42 GMT 2023
|
PRIMARY | Merck Index | ||
|
7601-90-3
Created by
admin on Fri Dec 15 18:48:42 GMT 2023 , Edited by admin on Fri Dec 15 18:48:42 GMT 2023
|
PRIMARY | |||
|
1140
Created by
admin on Fri Dec 15 18:48:42 GMT 2023 , Edited by admin on Fri Dec 15 18:48:42 GMT 2023
|
PRIMARY | |||
|
100000141410
Created by
admin on Fri Dec 15 18:48:42 GMT 2023 , Edited by admin on Fri Dec 15 18:48:42 GMT 2023
|
PRIMARY | |||
|
DTXSID8047004
Created by
admin on Fri Dec 15 18:48:42 GMT 2023 , Edited by admin on Fri Dec 15 18:48:42 GMT 2023
|
PRIMARY | |||
|
231-512-4
Created by
admin on Fri Dec 15 18:48:42 GMT 2023 , Edited by admin on Fri Dec 15 18:48:42 GMT 2023
|
PRIMARY | |||
|
29221
Created by
admin on Fri Dec 15 18:48:42 GMT 2023 , Edited by admin on Fri Dec 15 18:48:42 GMT 2023
|
PRIMARY | |||
|
PERCHLORIC ACID
Created by
admin on Fri Dec 15 18:48:42 GMT 2023 , Edited by admin on Fri Dec 15 18:48:42 GMT 2023
|
PRIMARY | |||
|
SUB91696
Created by
admin on Fri Dec 15 18:48:42 GMT 2023 , Edited by admin on Fri Dec 15 18:48:42 GMT 2023
|
PRIMARY | |||
|
24247
Created by
admin on Fri Dec 15 18:48:42 GMT 2023 , Edited by admin on Fri Dec 15 18:48:42 GMT 2023
|
PRIMARY | |||
|
V561V90BG2
Created by
admin on Fri Dec 15 18:48:42 GMT 2023 , Edited by admin on Fri Dec 15 18:48:42 GMT 2023
|
PRIMARY | |||
|
D010472
Created by
admin on Fri Dec 15 18:48:42 GMT 2023 , Edited by admin on Fri Dec 15 18:48:42 GMT 2023
|
PRIMARY |
SALT/SOLVATE (PARENT)
SALT/SOLVATE (PARENT)
SALT/SOLVATE (PARENT)
SALT/SOLVATE (PARENT)
SALT/SOLVATE (PARENT)
SALT/SOLVATE (PARENT)
SALT/SOLVATE (PARENT)
SALT/SOLVATE (PARENT)
SALT/SOLVATE (PARENT)
SUBSTANCE RECORD
